1. Omega-3 free fatty acids inhibit tamoxifen-induced cell apoptosis
   Shufan Wu et al, 2015, Biochemical and Biophysical Research Communications CrossRef
2. GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells
   Yue Zhang et al, 2023, Oncogene CrossRef
3. Reduced IQGAP2 expression promotes EMT and inhibits apoptosis by modulating the MEK-ERK and p38 signaling in breast cancer irrespective of ER status
   Dinesh Kumar et al, 2021, Cell Death & Disease CrossRef
4. The role of sex hormones and steroid receptors on female reproductive cancers
   Luiz Gustavo de Almeida Chuffa et al, 2017, Steroids CrossRef
5. Cytokine and inflammatory mediators are associated with cytotoxic, anti-inflammatory and apoptotic activity of honeybee venom
   Mohamed A. Salama et al, 2021, Journal of Complementary and Integrative Medicine CrossRef
6. Combination of low-concentration of novel phytoestrogen (8,9)-furanyl-pterocarpan-3-ol from Pachyrhizus erosus attenuated tamoxifen-associated growth inhibition on breast cancer T47D cells
   Arief Nurrochmad et al, 2013, Asian Pacific Journal of Tropical Biomedicine CrossRef
7. Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals
   Jingtao Zhong et al, 2018, International Journal of Molecular Medicine CrossRef
8. Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects
   Yoko Omoto et al, 2015, Cancer Science CrossRef
9. Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells
   Asefeh Dahmardeh Ghalehno et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
10. Co-culture hydrogel micro-chamber array-based plate for anti-tumor drug development at single-element resolution
    Yana Shafran et al, 2021, Toxicology in Vitro CrossRef
11. Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
    Charalampos Filippou et al, 2024, International Journal of Molecular Sciences CrossRef
12. The Impact of Anti-tumor Agents on ER-Positive MCF-7 and HER2-Positive SKBR-3 Breast Cancer Cells Biomechanics
    Despoina N. Metsiou et al, 2019, Annals of Biomedical Engineering CrossRef
13. Therapeutic advances in BIG3‐PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
    Tetsuro Yoshimaru et al, 2015, Cancer Science CrossRef
14. High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study
    Yanhong Su et al, 2021, Therapeutic Advances in Medical Oncology CrossRef
15. Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer
    John J. Kim et al, 2021, PLOS ONE CrossRef
16. Challenges of Endocrine Therapy in Breast Cancer
    Sepideh Mansouri et al, 2017, Cancer Genetics and Psychotherapy CrossRef
17. GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer
    Luis Molina et al, 2017, Expert Opinion on Therapeutic Targets CrossRef